feed,title,long_url,short_url
InsiderMonkey,"Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults",https://insidermonkey.com/blog/--1596341,
InsiderMonkey,"Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition",https://insidermonkey.com/blog/--1596339,
InsiderMonkey,AbCellera Biologics Inc. (ABCL) Launches First Human Trial for Menopause Therapy,https://insidermonkey.com/blog/--1596337,
InsiderMonkey,"ImmunityBio, Inc. (IBRX) Targets Lymphopenia with Cancer BioShield™ Platform",https://insidermonkey.com/blog/--1596335,
InsiderMonkey,"Merck & Co., Inc. (MRK) Expands Targeted Therapy Pipeline with ADC Advances",https://insidermonkey.com/blog/--1596331,
InsiderMonkey,"FDA Approves Regeneron Pharmaceuticals, Inc. (REGN)’s Linvoseltamab for Multiple Myeloma",https://insidermonkey.com/blog/--1596329,
InsiderMonkey,AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025,https://insidermonkey.com/blog/--1596326,
InsiderMonkey,Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN Partnership,https://insidermonkey.com/blog/--1596324,
InsiderMonkey,"Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine",https://insidermonkey.com/blog/--1596322,
InsiderMonkey,"Arcellx, Inc. (ACLX) Reports 97% Response Rate in CAR-T Trial",https://insidermonkey.com/blog/--1596319,
InsiderMonkey,BeOne Medicines Ltd. (ONC) Unveils Promising Breast Cancer Therapies at ASCO 2025,https://insidermonkey.com/blog/--1596316,
InsiderMonkey,Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments,https://insidermonkey.com/blog/--1596307,
InsiderMonkey,BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal,https://insidermonkey.com/blog/--1596303,
